Research Article
No access
Published Online: 7 July 2004

Type I Interferon Is the Primary Regulator of Inducible Ly-6C Expression on T Cells

Publication: Journal of Interferon & Cytokine Research
Volume 21, Issue Number 8

Abstract

Ly-6C has been proposed as a marker of memory CD8+ T cells. Reports have indicated that Ly-6C is upregulated after T cell receptor (TCR) stimulation or exposure to proinflammatory cytokines. This study examined the relative roles of proinflammatory cytokines and TCR engagement in Ly-6C induction. In vitro experiments tested the effects of cytokines on Ly-6C expression and confirmed interferon-α (IFN-α) as a primary cytokine that induces Ly-6C expression on CD4+ and CD8+ T cells. The amount and duration of Ly-6C expression were examined on T cells after in vivo induction of proinflammatory cytokines (CpG oligodeoxynucleotides [ODN]) or TCR activation (staphylococcal enterotoxin B [SEB]). In vivo, proinflammatory cytokines transiently upregulated Ly-6C on T cells in the absence of TCR stimulation. TCR stimulation by SEB transiently upregulated Ly-6C expression on antigen-specific and antigen-nonspecific T cells but did not cause long-term upregulation of Ly-6C expression in either population. IFN-α was confirmed as a primary inducer of Ly-6C in vivo, as CpG ODN were unable to induce Ly-6C expression in IFN-αRI-/- mice. Thus, inducible Ly-6C expression on CD4+ and CD8+ T cells is largely due to IFN-α in the environment and appears not to be directly correlated with the development of T cell memory.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

cover image Journal of Interferon & Cytokine Research
Journal of Interferon & Cytokine Research
Volume 21Issue Number 8August 2001
Pages: 621 - 629
PubMed: 11559440

History

Published online: 7 July 2004
Published in print: August 2001

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Annette J. Schlueter
Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242-1181
Arthur M. Krieg
Coley Pharmaceutical Group, Wellesley, MA 02481
Peter de Vries
Cell Therapeutics, Inc., Seattle, WA 98119
Xiang Li
Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242-1181

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Back to Top